Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$161.52+0.73 (+0.45%)
Close on Nov 2, 2026Market cap $308.21BP/E 22.6Yield –
Novartis CapEx PPE: -$392M in Q3 2026, up 10.7% from a year earlier.
Latest, Q3 2026
-392
Period ended Sep 30, 2026
Change on a year earlier
+10.7%
-354 in Q3 2025
History
31 quarters
Since Q1 2019
Sources
27
Documents cited below
Where the Q3 2026 figure comes from
“|| Purchases of property, plant and equipment | – 392 | – 354”
Source: Novartis Form 6-K (0001114448-26-000014) ↗
Reported in Form 6-K.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Novartis CapEx PPE ($M), quarterly Q1 2019–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-cf-capex-ppe
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.